Commission File Number 001-31914
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934
December 16, 2021
China Life Insurance Company Limited
(Translation of registrants name into English)
16 Financial Street
Xicheng District
Beijing 100033, China
Tel: (86-10) 6363-3333
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F:
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934:
Yes ☐ No ☒
If Yes is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- ☐
Commission File Number 001-31914
On December 16, 2021, China Life Insurance Company Limited issued two announcements in Chinese, the English translations of which are attached as Exhibit 99.1 and Exhibit 99.2 hereto.
EXHIBIT LIST
Exhibit | Description | |
99.1 | English translation of the announcement, dated December 16, 2021 | |
99.2 | English translation of the announcement, dated December 16, 2021 |
Commission File Number 001-31914
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
China Life Insurance Company Limited | ||||||
(Registrant) | ||||||
By: | /s/ Su Hengxuan | |||||
(Signature) | ||||||
December 16, 2021 | Name: Su Hengxuan Title: President and Executive Director |
EXHIBIT 99.1
Commission File Number 001-31914
中 國 人 壽 保 險 股 份 有 限 公 司
CHINA LIFE INSURANCE COMPANY LIMITED
(A joint stock limited company incorporated in the Peoples Republic of China with limited liability)
(the Company)
(Stock Code: 2628)
Announcement on the Resolutions of the Fifth Meeting of the Seventh Session of the Board
of Directors of China Life Insurance Company Limited
The fifth meeting (the Meeting) of the seventh session of the Board of Directors (the Board) of China Life Insurance Company Limited (the Company) was held on December 16, 2021 in Beijing. The directors were notified of the Meeting by way of a written notice dated December 2, 2021. Out of the Companys ten directors, eight directors attended the Meeting. Su Hengxuan and Li Mingguang, executive directors of the Company, and Yuan Changqing and Wang Junhui, non-executive directors of the Company, attended the Meeting in person. Tang Xin, Leung-Oi-Sie Elsie, Lam Chi Kuen and Zhai Haitao, independent directors of the Company, attended the Meeting by way of video conference. Wang Bin, chairman and executive director of the Company, was on leave for other business and authorized in writing, Su Hengxuan, executive director of the Company, to act on his behalf, cast the votes for him and preside over the Meeting. Huang Xiumei, executive director of the Company, was on leave for other business and authorized in writing, Leung-Oi-Sie Elsie, independent director of the Company, to act on her behalf and cast the votes for her. Supervisors and members of the management of the Company also attended the Meeting as non-voting delegates. The time, venue of the Meeting and the manner in which the Meeting was convened are in accordance with the Company Law of the Peoples Republic of China and the provisions under relevant laws, administrative regulations, departmental rules, Articles of Association and Rules of Procedures for the Board of Directors of the Company.
The Meeting was presided over by Su Hengxuan, executive director of the Company. The directors who attended the Meeting unanimously passed the following resolutions after sufficient review and discussion:
1. | The Proposal regarding Allocation Plan for the Companys Strategic Assets (Year 2022 - 2024) |
Voting result: 10 for, 0 against, with no abstention
2. | The Proposal regarding the Asset Allocation Plan of the Company (Year 2022) |
Voting result: 10 for, 0 against, with no abstention
3. | The Proposal regarding the Administration Guidelines for Investment Entrusted by the Company to China Life Investment Management Company Limited (Year 2022) |
Voting result: 10 for, 0 against, with no abstention
Commission File Number 001-31914
4. | The Proposal regarding the Authorization for Market-oriented Entrusted Investment for RMB Assets of the Company (Year 2022) |
Voting result: 10 for, 0 against, with no abstention
5. | The Proposal regarding the Companys Overseas Investment Plan and Investment Authorization (Year 2022) |
Voting result: 10 for, 0 against, with no abstention
6. | The Proposal regarding the Authorization for the Companys Investment in Non-self-use Real Properties (Year 2022) |
Voting result: 10 for, 0 against, with no abstention
7. | The Proposal regarding the Authorization for the Companys Investment in Equity Investment Funds (Year 2022) |
Voting result: 10 for, 0 against, with no abstention
8. | The Proposal regarding the Authorization for the Companys Non-listed Equity Investment (Year 2022) |
Voting result: 10 for, 0 against, with no abstention
9. | The Proposal regarding the Authorization for the Companys Investment in Financial Products (Year 2022) |
Voting result: 10 for, 0 against, with no abstention
10. | The Proposal regarding the Authorization for Matters relating to Special Reserve for the Companys Universal Insurance Business |
Voting result: 10 for, 0 against, with no abstention
11. | The Proposal regarding the Authorization for Matters relating to Management of Reserve for the Companys Non-Life Insurance Business |
Voting result: 10 for, 0 against, with no abstention
12. | The Proposal regarding the Formulation of Interim Measures for the Administration of Undertakings of Major Shareholders of the Company |
Voting result: 10 for, 0 against, with no abstention
13. | The Proposal regarding the Renewal of the Entrusted Investment Management Agreement with Insurance Funds with China Life Franklin Asset Management Co., Limited |
This transaction constitutes a related party transaction under the rules of the China Banking and Insurance Regulatory Commission. Affiliated directors, including Wang Bin, Su Hengxuan, Huang Xiumei, Yuan Changqing and Wang Junhui abstained from voting on this proposal. The independent directors gave their independent opinions and agreed on the proposal.
Commission File Number 001-31914
Voting result: 5 for, 0 against, with no abstention
14. | The Proposal regarding the Renewal of the Related Party Framework Agreement for Bonds Distribution with China Life Asset Management Company Limited |
This transaction constitutes a related party transaction under the rules of the China Banking and Insurance Regulatory Commission. Affiliated directors, including Wang Bin, Su Hengxuan, Huang Xiumei, Yuan Changqing and Wang Junhui abstained from voting on this proposal. The independent directors gave their independent opinions and agreed on the proposal.
Voting result: 5 for, 0 against, with no abstention
15. | The Proposal regarding the Renewal of the Framework Agreement on Connected Transaction with Sino-Ocean Group Holding Limited |
Affiliated director Huang Xiumei abstained from voting on this proposal. The independent directors gave their independent opinions and agreed on the proposal. Please refer to a separate announcement filed by the Company on the website of Shanghai Stock Exchange (www.sse.com.cn) on the same date of this announcement for detailed information.
Voting result: 9 for, 0 against, with no abstention
16. | The Proposal on the Companys Investment in China Life Smart Medical Fund Project |
Affiliated directors, including Wang Bin, Su Hengxuan, Yuan Changqing and Wang Junhui abstained from voting on this proposal. The independent directors gave their independent opinions and agreed on the proposal. Please refer to a separate announcement filed by the Company on the website of Shanghai Stock Exchange (www.sse.com.cn) on the same date of this announcement for detailed information.
Voting result: 6 for, 0 against, with no abstention
17. | The Proposal on the Companys Investment in China Life Chengxin No.1 Asset-backed Plan |
This transaction constitutes a connected transaction under the listing rules of the Hong Kong Stock Exchange and a related party transaction under the rules of the China Banking and Insurance Regulatory Commission. Affiliated directors, including Wang Bin, Su Hengxuan, Huang Xiumei, Yuan Changqing and Wang Junhui, abstained from voting on this proposal. The independent directors gave their independent opinions and agreed on the proposal. For details, please refer to a separate announcement filed on the same date of this announcement on the website of Hong Kong Stock Exchange.
Voting result: 5 for, 0 against, with no abstention
18. | The Proposal on the Companys Investment in China Life Investment Xinyuan No.1 Equity Investment Plan |
Commission File Number 001-31914
Affiliated directors, including Wang Bin, Su Hengxuan, Yuan Changqing and Wang Junhui abstained from voting on this proposal. The independent directors gave their independent opinions and agreed on the proposal. Please refer to a separate announcement filed by the Company on the website of Shanghai Stock Exchange (www.sse.com.cn) on the same date of this announcement for detailed information.
Voting result: 6 for, 0 against, with no abstention
19. | The Proposal on the Companys Investment in China Life Investment Xindian No.1 Equity Investment Plan |
Affiliated directors, including Wang Bin, Su Hengxuan, Yuan Changqing and Wang Junhui abstained from voting on this proposal. The independent directors gave their independent opinions and agreed on the proposal. Please refer to a separate announcement filed by the Company on the website of Shanghai Stock Exchange (www.sse.com.cn) on the same date of this announcement for detailed information.
Voting result: 6 for, 0 against, with no abstention
20. | The Proposal regarding Renewal of the Daily Connected Transaction Framework Agreement with China Life Pension Company Limited |
This transaction constitutes a related party transaction under the rules of the China Banking and Insurance Regulatory Commission. Affiliated directors, including Wang Bin, Su Hengxuan, Li Mingguang, Yuan Changqing and Wang Junhui abstained from voting on this proposal. The independent directors gave their independent opinions and agreed on the proposal.
Voting result: 5 for, 0 against, with no abstention
21. | The Proposal regarding Renewal of the Policy Management Agreement between the Company and China Life Insurance (Group) Company |
Affiliated directors, including Wang Bin, Su Hengxuan, Yuan Changqing and Wang Junhui abstained from voting on this proposal. The independent directors gave their independent opinions and agreed on the proposal. Please refer to a separate announcement filed by the Company on the website of Shanghai Stock Exchange (www.sse.com.cn) on the same date of this announcement for detailed information.
Voting result: 6 for, 0 against, with no abstention
22. | The Proposal regarding the Companys Fraud Risk Management Work Report for 2021 |
Voting result: 10 for, 0 against, with no abstention
23. | The Proposal regarding Amendment of Measures for the Overall Risk Management and Other Relevant Rules of the Company |
Voting result: 10 for, 0 against, with no abstention
Board of Directors of China Life Insurance Company Limited
December 16, 2021
EXHIBIT 99.2
Commission File Number 001-31914
中 國 人 壽 保 險 股 份 有 限 公 司
CHINA LIFE INSURANCE COMPANY LIMITED
(A joint stock limited company incorporated in the Peoples Republic of China with limited liability)
(the Company)
(Stock Code: 2628)
Announcement on the Resolutions of the Fourth Meeting of the Seventh Session of the
Board of Supervisors of China Life Insurance Company Limited
The fourth meeting (the Meeting) of the seventh session of the Board of Supervisors of the Company (the Board of Supervisors) was held on December 16, 2021 in Beijing. The supervisors were notified of the Meeting by way of a written notice dated December 2, 2021. All of the Companys five supervisors attended the Meeting in person, including Jia Yuzeng, chairperson of the Board of Supervisors, and Niu Kailong, Cao Qingyang, Wang Xiaoqing and Lai Jun, supervisors of the Company. The time, venue and the manner in which the Meeting was convened are in accordance with the Company Law of the Peoples Republic of China and the provisions under relevant laws, administrative regulations, departmental rules, Articles of Association and Rules of Procedures for the Board of Supervisors of the Company.
The Meeting was presided over by Chairperson Jia Yuzeng. The supervisors who were present passed the following resolutions unanimously after sufficient review and discussion:
1. | The Proposal regarding the 2022 Work Plan of the Board of Supervisors of the Company |
Voting result: 5 for, 0 against, with no abstention
Board of Supervisors of China Life Insurance Company Limited
December 16, 2021